肿瘤学中的价值：因人而异。 - Suppr

Suppr

超能文献

Value in Oncology: It Is in the Eyes of the Beholder.

作者信息

Nabhan Chadi, Phillips Eli G, Feinberg Bruce A

出版信息

J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092.

DOI:10.6004/jnccn.2018.7092

PMID:30659123

Abstract

摘要

相似文献

Value in Oncology: It Is in the Eyes of the Beholder.

J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092.

Tackling Cost: A Prescription for Spending Wisely.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):633. doi: 10.6004/jnccn.2019.0030.

Targeted immunotherapies overtaking emerging oncology market value based growth.

J BUON. 2015 Jan-Feb;20(1):350-1.

Seeking value as cancer drug costs soar.

Cancer Discov. 2013 Aug;3(8):833-4. doi: 10.1158/2159-8290.CD-ND2013-018. Epub 2013 Aug 1.

Many new cancer drugs in the United Kingdom are facing negative NICE rulings.

J Clin Oncol. 2007 Jun 20;25(18):2635-6; author reply 2637-8. doi: 10.1200/JCO.2007.11.4272.

Can cancer care lead the way toward a value-based future?

Am J Manag Care. 2019 Dec;25(12 Spec No.):SP377-SP378.

Perspectives on Cost and Value in Cancer Care.

JAMA Oncol. 2016 Jan;2(1):19-21. doi: 10.1001/jamaoncol.2015.4191.

Cancer care value-learning from others.

Am J Manag Care. 2012 May;18(3 Spec No.):SP139.

United healthcare, five oncology practices try bundled payments.

J Natl Cancer Inst. 2011 Jan 5;103(1):8-10. doi: 10.1093/jnci/djq538. Epub 2010 Dec 17.

The shortage of essential chemotherapy drugs in the United States.

N Engl J Med. 2011 Nov 3;365(18):1653-5. doi: 10.1056/NEJMp1109772. Epub 2011 Oct 31.

引用本文的文献

Can cancer go green? It's up to us.

Front Oncol. 2023 Feb 22;13:1074091. doi: 10.3389/fonc.2023.1074091. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Value in Oncology: It Is in the Eyes of the Beholder.

J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092.

Tackling Cost: A Prescription for Spending Wisely.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):633. doi: 10.6004/jnccn.2019.0030.

Targeted immunotherapies overtaking emerging oncology market value based growth.

J BUON. 2015 Jan-Feb;20(1):350-1.

Seeking value as cancer drug costs soar.

Cancer Discov. 2013 Aug;3(8):833-4. doi: 10.1158/2159-8290.CD-ND2013-018. Epub 2013 Aug 1.

Many new cancer drugs in the United Kingdom are facing negative NICE rulings.

J Clin Oncol. 2007 Jun 20;25(18):2635-6; author reply 2637-8. doi: 10.1200/JCO.2007.11.4272.

Can cancer care lead the way toward a value-based future?

Am J Manag Care. 2019 Dec;25(12 Spec No.):SP377-SP378.

Perspectives on Cost and Value in Cancer Care.

JAMA Oncol. 2016 Jan;2(1):19-21. doi: 10.1001/jamaoncol.2015.4191.

Cancer care value-learning from others.

Am J Manag Care. 2012 May;18(3 Spec No.):SP139.

United healthcare, five oncology practices try bundled payments.

J Natl Cancer Inst. 2011 Jan 5;103(1):8-10. doi: 10.1093/jnci/djq538. Epub 2010 Dec 17.

The shortage of essential chemotherapy drugs in the United States.

N Engl J Med. 2011 Nov 3;365(18):1653-5. doi: 10.1056/NEJMp1109772. Epub 2011 Oct 31.

引用本文的文献

Can cancer go green? It's up to us.

Front Oncol. 2023 Feb 22;13:1074091. doi: 10.3389/fonc.2023.1074091. eCollection 2023.